{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:15:00Z","timestamp":1794453300757,"version":"4.9.1"},"reference-count":218,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hyper IgE syndromes (HIES) form a rare group of primary immunodeficiency disorders (PIDs) distinguished by persistent skin abscesses, dermatitis, allergies, and infections, in addition to their characteristic high serum IgE levels. Autosomal dominant (AD) and autosomal recessive (AR) genetic defects have been reported in HIES. From a clinical perspective, AD-HIES cases generally exhibit several non-immunologic features, including connective tissue, dental and skeletal abnormalities, whilst AR-HIES conditions have a higher incidence of neurologic complications and cutaneous viral infections. Genetic defects associated with HIES lead to impaired immune signaling, affecting pathways crucial for immune cell development, function, and immune response to pathogens\/allergens. As a result, HIES patients are predisposed to recurrent bacterial and\/or fungal infections, as well as atopic allergic responses. In many cases, the exact biological mechanisms responsible for the variations observed in the clinical phenotypes between the two inherited forms of HIES are still unclear. In this review, we describe the genetic basis of HIES with a distinction between the AR-HIES and AD-HIES forms, to better comprehend the different underlying molecular mechanisms, a distinction which is imperative for the accurate diagnosis, management, and development of targeted therapies for HIES patients.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1516068","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:52:01Z","timestamp":1739861521000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["The genetics of hyper IgE syndromes"],"prefix":"10.3389","volume":"16","author":[{"given":"Randa","family":"AlYafie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Velayutham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"van Panhuys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthen Veettil","family":"Jithesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.alit.2021.07.007","article-title":"Hyper-IgE syndrome, 2021 update","volume":"70","author":"Minegishi","year":"2021","journal-title":"Allergol Int"},{"key":"B2","doi-asserted-by":"publisher","first-page":"108988","DOI":"10.1016\/j.clim.2022.108988","article-title":"Hyper IgE syndromes: A clinical approach","volume":"237","author":"Gharehzadehshirazi","year":"2022","journal-title":"Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MD.0b013e31825f95b9","article-title":"Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey","volume":"91","author":"Chandesris","year":"2012","journal-title":"Med (Baltimore)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/all.2018.73.issue-11","article-title":"Hyper-IgE in the allergy clinic\u2013when is it primary immunodeficiency","volume":"73","author":"Ponsford","year":"2018","journal-title":"Allergy"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8707(66)90091-8","article-title":"Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin","volume":"37","author":"Ishizaka","year":"1966","journal-title":"J Allergy"},{"key":"B6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/ar4069","article-title":"An update on the hyper-IgE syndromes","volume":"14","author":"Yong","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.09.009","article-title":"Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity","volume":"25","author":"Minegishi","year":"2006","journal-title":"Immunity"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01289-3","article-title":"Human inborn errors of immunity: 2022 update on the classification from the international union of immunological societies expert committee","volume":"42","author":"Tangye","year":"2022","journal-title":"J Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109364","article-title":"Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease","volume":"220","author":"Sharma","year":"2023","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jaci.2023.01.023","article-title":"Severe allergic dysregulation due to a gain of function mutation in the transcription factor STAT6","volume":"152","author":"Baris","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.05.007","article-title":"T(H)2-driven manifestations of inborn errors of immunity","volume":"154","author":"James","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860821","article-title":"Inborn errors of the immune system associated with atopy","volume":"13","author":"Nelson","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"B15","volume-title":"Online Mendelian Inheritance in Man, OMIM","year":"2025"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01228-5","article-title":"A systematic review regarding the prevalence of Malignancy in patients with the hyper-IgE syndrome","volume":"23","author":"Mohammadi","year":"2023","journal-title":"Clin Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191804","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202592","article-title":"Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance","volume":"218","author":"Asano","year":"2021","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jaci.2013.05.029","article-title":"Signal transducer and activator of transcription 3 (STAT3) mutations underlying autosomal dominant hyper-IgE syndrome impair human CD8(+) T-cell memory formation and function","volume":"132","author":"Ives","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.028","article-title":"The gamma(c) family of cytokines: basic biology to therapeutic ramifications","volume":"50","author":"Leonard","year":"2019","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1511711112","article-title":"Opposing roles of STAT1 and STAT3 in IL-21 function in CD4+ T cells","volume":"112","author":"Wan","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.02.011","article-title":"The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells","volume":"38","author":"Wan","year":"2013","journal-title":"Immunity"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-054973","article-title":"The molecular basis of IL-21-mediated proliferation","volume":"109","author":"Zeng","year":"2007","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.9.4710","article-title":"A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9","volume":"16","author":"Demoulin","year":"1996","journal-title":"Mol Cell Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90141-8","article-title":"The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15","volume":"2","author":"Lin","year":"1995","journal-title":"Immunity"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1202117","article-title":"JAKs and STATs in immunity, immunodeficiency, and cancer","volume":"368","author":"O\u2019Shea","year":"2013","journal-title":"N Engl J Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01012-1","article-title":"IL-6 prevents Th2 cell polarization by promoting SOCS3-dependent suppression of IL-2 signaling","volume":"20","author":"Bachus","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0237137100","article-title":"STAT3 deletion during hematopoiesis causes Crohn\u2019s disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity","volume":"100","author":"Welte","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.002","article-title":"Cytokine signaling modules in inflammatory responses","volume":"28","author":"O\u2019Shea","year":"2008","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.08.002","article-title":"Reduced memory B cells in patients with hyper IgE syndrome","volume":"129","author":"Speckmann","year":"2008","journal-title":"Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jaci.2010.06.029","article-title":"Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis","volume":"126","author":"Schimke","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.4.2347","article-title":"Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways","volume":"162","author":"Laan","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91942-4","article-title":"Defect in neutrophil granulocyte chemotaxis in Job\u2019s syndrome of recurrent \u201ccold\u201d staphylococcal abscesses","volume":"2","author":"Hill","year":"1974","journal-title":"Lancet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1600-065X.1978.tb01469.x","article-title":"Abnormalities in the regulation of human IgE synthesis","volume":"41","author":"Buckley","year":"1978","journal-title":"Immunol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.09.016","article-title":"A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory","volume":"35","author":"Siegel","year":"2011","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00168","article-title":"Signal transducer and activator of transcription 3 control of human T and B cell responses","volume":"9","author":"Deenick","year":"2018","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.coi.2014.01.015","article-title":"STAT3 is a central regulator of lymphocyte differentiation and function","volume":"28","author":"Kane","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","article-title":"DoubletFinder: doublet detection in single-cell RNA sequencing data using artificial nearest neighbors","volume":"8","author":"McGinnis","year":"2019","journal-title":"Cell Syst"},{"key":"B39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imlet.2013.11.005","article-title":"Proximity of TCR and its CD8 coreceptor controls sensitivity of T cells","volume":"157","author":"Borger","year":"2014","journal-title":"Immunol Lett"},{"key":"B40","doi-asserted-by":"publisher","first-page":"112512","DOI":"10.1016\/j.celrep.2023.112512","article-title":"STAT3 signaling in B cells controls germinal center zone organization and recycling","volume":"42","author":"Fike","year":"2023","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/JCI111683","article-title":"Immunoglobulins in the hyperimmunoglobulin E and recurrent infection (Job\u2019s) syndrome. Deficiency of anti-Staphylococcus aureus immunoglobulin A","volume":"75","author":"Dreskin","year":"1985","journal-title":"J Clin Invest"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90873-1","article-title":"Impaired antibody responses in the hyperimmunoglobulin E syndrome","volume":"81","author":"Leung","year":"1988","journal-title":"J Allergy Clin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(91)90126-9","article-title":"Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome","volume":"87","author":"Sheerin","year":"1991","journal-title":"J Allergy Clin Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jaci.2011.09.017","article-title":"Heterozygous signal transducer and activator of transcription 3 mutations in hyper-IgE syndrome result in altered B-cell maturation","volume":"129","author":"Meyer-Bahlburg","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091706","article-title":"B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans","volume":"207","author":"Avery","year":"2010","journal-title":"J Exp Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.2019.97.issue-4","article-title":"Hyper IgE syndromes: clinical and molecular characteristics","volume":"97","author":"Al-Shaikhly","year":"2019","journal-title":"Immunol Cell Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix140","article-title":"Reduced immunoglobulin (Ig) G response to Staphylococcus aureus in STAT3 hyper-IgE syndrome","volume":"64","author":"Stentzel","year":"2017","journal-title":"Clin Infect Dis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0369-7","article-title":"Clinical manifestations and genetic analysis of 17 patients with autosomal dominant Hyper-IgE syndrome in Mainland China: new reports and a literature review","volume":"37","author":"Wu","year":"2017","journal-title":"J Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1111\/sji.2013.78.issue-3","article-title":"Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China","volume":"78","author":"Zhang","year":"2013","journal-title":"Scand J Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections\u2013an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.aller.2018.07.009","article-title":"Phenotyping and long-term follow up of patients with hyper IgE syndrome","volume":"47","author":"Alyasin","year":"2019","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201847650","article-title":"Eosinophilia and reduced STAT3 signaling affect neutrophil cell death in autosomal-dominant Hyper-IgE syndrome","volume":"48","author":"Farmand","year":"2018","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1161\/CIRCGENETICS.111.961235","article-title":"Frequent and widespread vascular abnormalities in human signal transducer and activator of transcription 3 deficiency","volume":"5","author":"Chandesris","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1086\/302547","article-title":"Genetic linkage of hyper-IgE syndrome to chromosome 4","volume":"65","author":"Grimbacher","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s13023-020-01516-3","article-title":"Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential","volume":"15","author":"Meixner","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012098655-2\/50031-4","article-title":"Epidemiology and consequences of osteoporotic\u00a0fractures","volume-title":"The aging skeleton","author":"Ross","year":"1999"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-013-9982-2","article-title":"Bone density and fractures in autosomal dominant hyper IgE syndrome","volume":"34","author":"Sowerwine","year":"2014","journal-title":"J Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-01051-1","article-title":"STAT3 hyper-IgE syndrome-an update and unanswered questions","volume":"41","author":"Tsilifis","year":"2021","journal-title":"J Clin Immunol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.03.016","article-title":"Inborn errors of human JAKs and STATs","volume":"36","author":"Casanova","year":"2012","journal-title":"Immunity"},{"key":"B60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2011.01.001","article-title":"Paucity of genotype-phenotype correlations in STAT3 mutation positive Hyper IgE Syndrome (HIES)","volume":"139","author":"Heimall","year":"2011","journal-title":"Clin Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00971-2","article-title":"Hematopoietic stem cell transplantation resolves the immune deficit associated with STAT3-dominant-negative hyper-IgE syndrome","volume":"41","author":"Harrison","year":"2021","journal-title":"J Clin Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2016.12.168","article-title":"Allogeneic bone marrow transplantation for STAT3 deficiency","volume":"23","author":"Dimitrova D","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028415","article-title":"Interleukin-6 family cytokines","volume":"10","author":"Rose-John","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","article-title":"The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells","volume":"15","author":"Seif","year":"2017","journal-title":"Cell Commun Signal"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1084\/jem.2019180405272020c","article-title":"Correction: Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J Exp Med"},{"key":"B66","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.7.3555","article-title":"IgE versus IgG4 production can be differentially regulated by IL-10","volume":"160","author":"Jeannin","year":"1998","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00295-9","article-title":"IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity","volume":"16","author":"Kasaian","year":"2002","journal-title":"Immunity"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.1077002","article-title":"A critical role for IL-21 in regulating immunoglobulin production","volume":"298","author":"Ozaki","year":"2002","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-142745","article-title":"STAT3 is required for IL-21-induced secretion of IgE from human naive B cells","volume":"112","author":"Avery","year":"2008","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"102286","DOI":"10.1016\/j.coi.2023.102286","article-title":"Cytokine-mediated STAT-dependent pathways underpinning human B-cell differentiation and function","volume":"81","author":"Tangye","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.04.045","article-title":"Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy","volume":"143","author":"Kotlarz","year":"2012","journal-title":"Gastroenterology"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1093\/cei\/uxac040","article-title":"The clinical, molecular, and therapeutic features of patients with IL10\/IL10R deficiency: a systematic review","volume":"208","author":"Sharifinejad","year":"2022","journal-title":"Clin Exp Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajhg.2011.05.024","article-title":"Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth","volume":"89","author":"Nieminen","year":"2011","journal-title":"Am J Hum Genet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2021.04.007","article-title":"Inborn errors of IL-6 family cytokine responses","volume":"72","author":"Chen","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190344","article-title":"Loss of the interleukin-6 receptor causes immunodeficiency, atopy, and abnormal inflammatory responses","volume":"216","author":"Spencer","year":"2019","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jaci.2019.11.015","article-title":"Defining the biological responses of IL-6 by the study of a novel IL-6 receptor chain immunodeficiency","volume":"145","author":"Nahum","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191306","article-title":"Absence of GP130 cytokine receptor signaling causes extended Stuve-Wiedemann syndrome","volume":"217","author":"Chen","year":"2020","journal-title":"J Exp Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.2013.1.issue-4","article-title":"Mutations in the interleukin receptor IL11RA cause autosomal recessive Crouzon-like craniosynostosis","volume":"1","author":"Keupp","year":"2013","journal-title":"Mol Genet Genomic Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/ng.744","article-title":"Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis","volume":"43","author":"van de Laar","year":"2011","journal-title":"Nat Genet"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.111.248161","article-title":"Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms","volume":"109","author":"Regalado","year":"2011","journal-title":"Circ Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2349","article-title":"Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm","volume":"44","author":"Lindsay","year":"2012","journal-title":"Nat Genet"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2348","article-title":"TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome","volume":"44","author":"Boileau","year":"2012","journal-title":"Nat Genet"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/ng1511","article-title":"A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2","volume":"37","author":"Loeys","year":"2005","journal-title":"Nat Genet"},{"key":"B90","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13019-023-02322-1","article-title":"Ten-year follow-up study of a young woman with loeys-dietz syndrome: a case report","volume":"18","author":"Nakajima","year":"2023","journal-title":"J Cardiothorac Surg"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1111\/cge.2014.86.issue-6","article-title":"Detection of 15 novel mutations in 52 children from 40 families with the Marfan or Loeys-Dietz syndrome and phenotype-genotype correlations","volume":"86","author":"Pees","year":"2014","journal-title":"Clin Genet"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.715687","article-title":"Mouse model of Loeys-Dietz syndrome shows elevated susceptibility to periodontitis via alterations in transforming growth factor-beta signaling","volume":"12","author":"Yamada","year":"2021","journal-title":"Front Physiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601882","article-title":"Cutting edge: active TGF-beta1 released from GARP\/TGF-beta1 complexes on the surface of stimulated human B lymphocytes increases class-switch recombination and production of IgA","volume":"199","author":"Dedobbeleer","year":"2017","journal-title":"J Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.12.8153","article-title":"Cell intrinsic TGF-beta 1 regulation of B cells","volume":"180","author":"Gros","year":"2008","journal-title":"J Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coi.2019.05.002","article-title":"Genetic evidence for the role of transforming growth factor-beta in atopic phenotypes","volume":"60","author":"Weissler","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.07.012","article-title":"Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor","volume":"25","author":"Marie","year":"2006","journal-title":"Immunity"},{"key":"B97","doi-asserted-by":"publisher","first-page":"195ra94","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGFbeta receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320319111","article-title":"Thymocyte apoptosis drives the intrathymic generation of regulatory T cells","volume":"111","author":"Konkel","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1113061","article-title":"TGFbeta signaling pathways in human health and disease","volume":"10","author":"Chen","year":"2023","journal-title":"Front Mol Biosci"},{"key":"B100","doi-asserted-by":"publisher","first-page":"eadg8691","DOI":"10.1126\/sciimmunol.adg8691","article-title":"TGFbeta prevents IgE-mediated allergic disease by restraining T follicular helper 2 differentiation","volume":"9","author":"Haque","year":"2024","journal-title":"Sci Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2011.68","article-title":"Clinical utility gene card for: Loeys-Dietz syndrome (TGFBR1\/2) and related phenotypes","volume":"19","author":"Arslan-Kirchner","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-250587","article-title":"Infant with Loeys-Dietz syndrome treated for febrile status epilepticus with COVID-19 infection: first reported case of febrile status epilepticus and focal seizures in a patient with Loeys-Dietz syndrome and review of literature","volume":"15","author":"Akbar","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.23907\/2016.069","article-title":"A complex case of Loeys-Dietz syndrome: A case report and review of the literature","volume":"6","author":"Caza","year":"2016","journal-title":"Acad Forensic Pathol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"102353","DOI":"10.1016\/j.coi.2023.102353","article-title":"ERBIN and phosphoglucomutase 3 deficiency","volume":"84","author":"Milner","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.01.012","article-title":"Targeted IL-4Ralpha blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-beta signaling due to ERBIN deficiency","volume":"10","author":"Droghini","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0214-9","article-title":"TGFbeta1 single-nucleotide polymorphism C-509T alters mucosal cell function in pediatric eosinophilic esophagitis","volume":"13","author":"Duong","year":"2020","journal-title":"Mucosal Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1084\/jem.20140643","article-title":"mTOR inhibition rescues osteopenia in mice with systemic sclerosis","volume":"212","author":"Chen","year":"2015","journal-title":"J Exp Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med"},{"key":"B109","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12016-021-08881-2","article-title":"Novel genetic discoveries in primary immunodeficiency disorders","volume":"63","author":"Redmond","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-018-1910-3","article-title":"The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease","volume":"137","author":"Liu","year":"2018","journal-title":"Hum Genet"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.jaip.2022.01.011","article-title":"Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation","volume":"10","author":"James","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-050351","article-title":"Dupilumab for STAT3-hyper-IgE syndrome with refractory intestinal complication","volume":"148","author":"Lu","year":"2021","journal-title":"Pediatrics"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e13770","DOI":"10.1111\/pai.13770","article-title":"Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome","volume":"33","author":"Matucci-Cerinic","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"108452","DOI":"10.1016\/j.clim.2020.108452","article-title":"Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome","volume":"215","author":"Sogkas","year":"2020","journal-title":"Clin Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jaip.2021.08.042","article-title":"Relieving job: Dupilumab in autosomal dominant STAT3 hyper-IgE syndrome","volume":"10","author":"Staudacher","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.17889","article-title":"Dupilumab treatment of eczema in a child with STAT3 hyper-immunoglobulin E syndrome","volume":"36","author":"Wang","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1038\/ncomms6555","article-title":"Clustering of CARMA1 through SH3-GUK domain interactions is required for its activation of NF-kappaB signalling","volume":"6","author":"Hara","year":"2015","journal-title":"Nat Commun"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10875-014-0106-4","article-title":"Germline CARD11 mutation in a patient with severe congenital B cell lymphocytosis","volume":"35","author":"Brohl","year":"2015","journal-title":"J Clin Immunol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.jaci.2013.02.012","article-title":"Whole-exome sequencing links caspase recruitment domain 11 (CARD11) inactivation to severe combined immunodeficiency","volume":"131","author":"Greil","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3898","article-title":"Germline hypomorphic CARD11 mutations in severe atopic disease","volume":"49","author":"Ma","year":"2017","journal-title":"Nat Genet"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.jaci.2017.06.047","article-title":"Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11)","volume":"141","author":"Dadi","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.03.009","article-title":"Germline CBM-opathies: From immunodeficiency to atopy","volume":"143","author":"Lu","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14686","article-title":"Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant","volume":"46","author":"Charvet","year":"2021","journal-title":"Clin Exp Dermatol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1020927","article-title":"Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience","volume":"13","author":"Urdinez","year":"2022","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.878989","article-title":"Hyper-IgE and carcinoma in CADINS disease","volume":"13","author":"Pietzsch","year":"2022","journal-title":"Front Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01387-2","article-title":"Very early onset inflammatory bowel disease caused by a novel dominant negative mutation of caspase recruitment domain 11 (CARD11)","volume":"43","author":"Hu","year":"2023","journal-title":"J Clin Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"24247","DOI":"10.1038\/s41598-024-71673-z","article-title":"A new-disease-causing dominant-negative variant in CARD11 gene in a Chinese case with recurrent fever","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci Rep"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2009.101","article-title":"Differential requirements for IL-4\/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses","volume":"88","author":"Forbes","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2023.12.003","article-title":"Human germline gain-of-function in STAT6: from severe allergic disease to lymphoma and beyond","volume":"45","year":"2024","journal-title":"Trends Immunol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.06.011","article-title":"Genome-wide profiling of interleukin-4 and STAT6 transcription factor regulation of human Th2 cell programming","volume":"32","author":"Elo","year":"2010","journal-title":"Immunity"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/380627a0","article-title":"Essential role of Stat6 in IL-4 signalling","volume":"380","author":"Takeda","year":"1996","journal-title":"Nature"},{"key":"B133","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1742-2094-8-56","article-title":"Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism","volume":"8","author":"Sloka","year":"2011","journal-title":"J Neuroinflamm"},{"key":"B134","doi-asserted-by":"publisher","first-page":"895","DOI":"10.4049\/jimmunol.1601448","article-title":"Allergen-induced CD4+ T cell cytokine production within airway mucosal dendritic cell-T cell clusters drives the local recruitment of myeloid effector cells","volume":"198","author":"Veres","year":"2017","journal-title":"J Immunol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.24.6.4351","article-title":"Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism","volume":"24","author":"Matsukura","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.623","article-title":"CD11b+ myeloid cells are the key mediators of Th2 cell homing into the airway in allergic inflammation","volume":"182","author":"Medoff","year":"2009","journal-title":"J Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01530-7","article-title":"Autosomal dominant STAT6 gain of function causes severe atopy associated with lymphoma","volume":"43","author":"Minskaia","year":"2023","journal-title":"J Clin Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/972591","article-title":"Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome","volume":"29","author":"Zhang","year":"2010","journal-title":"Dis Markers"},{"key":"B140","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.jaci.2009.10.038","article-title":"Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome","volume":"124","author":"Engelhardt","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01352-z","article-title":"The 2022 update of IUIS phenotypical classification for human inborn errors of immunity","volume":"42","author":"Bousfiha","year":"2022","journal-title":"J Clin Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042259","article-title":"DOCK8 mutation in patient with juvenile idiopathic\u00a0arthritis and Sjogren\u2019s syndrome","volume":"25","author":"Opoka-Winiarska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-01-407098","article-title":"DOCK8 is a Cdc42 activator critical for interstitial dendritic cell migration during immune responses","volume":"119","author":"Harada","year":"2012","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2305","article-title":"DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation","volume":"13","author":"Jabara","year":"2012","journal-title":"Nat Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110345","article-title":"DOCK8 deficiency impairs CD8 T cell survival and function in humans and mice","volume":"208","author":"Randall","year":"2011","journal-title":"J Exp Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/143612","article-title":"The essential role of DOCK8 in humoral immunity","volume":"29","author":"Randall","year":"2010","journal-title":"Dis Markers"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1820","article-title":"Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production","volume":"10","author":"Randall","year":"2009","journal-title":"Nat Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270106","article-title":"Human T lymphocytes bind to germinal centers of human tonsils via integrin alpha4\/VCAM-1 and LFA-1\/ICAM-1 and -2","volume":"27","author":"Schriever","year":"1997","journal-title":"Eur J Immunol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ceb.2014.05.002","article-title":"T cell migration in intact lymph nodes in vivo","volume":"30","author":"Munoz","year":"2014","journal-title":"Curr Opin Cell Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20171129","article-title":"ICAMs support B cell interactions with T follicular helper cells and promote clonal selection","volume":"214","author":"Zaretsky","year":"2017","journal-title":"J Exp Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134508","article-title":"DOCK8 is essential for LFA-1-dependent positioning of T follicular helper cells in germinal centers","volume":"5","author":"Janssen","year":"2020","journal-title":"JCI Insight"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0795-1","article-title":"Migration-induced cell shattering due to DOCK8 deficiency causes a type 2-biased helper T cell response","volume":"21","author":"Schneider","year":"2020","journal-title":"Nat Immunol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jaci.2024.04.026","article-title":"Mechanisms underlying skin inflammation of DOCK8 deficiency","volume":"154","author":"Fusaro","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s10875-012-9664-5","article-title":"Additional diverse findings expand the clinical presentation of DOCK8 deficiency","volume":"32","author":"Sanal","year":"2012","journal-title":"J Clin Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905506","article-title":"Combined immunodeficiency associated with DOCK8 mutations","volume":"361","author":"Zhang","year":"2009","journal-title":"N Engl J Med"},{"key":"B156","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.2011.06295.x","article-title":"DOCK8 deficiency","volume":"1246","author":"Su","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.06.003","article-title":"Deficient T Cell Receptor Excision Circles (TRECs) in autosomal recessive hyper IgE syndrome caused by DOCK8 mutation: implications for pathogenesis and potential detection by newborn screening","volume":"141","author":"Dasouki","year":"2011","journal-title":"Clin Immunol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.clim.2017.06.003","article-title":"DOCK8 deficiency: Insights into pathophysiology, clinical features and management","volume":"181","author":"Biggs","year":"2017","journal-title":"Clin Immunol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1945","article-title":"The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency","volume":"136","author":"Engelhardt","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2018.10.035","article-title":"Hematopoietic stem cell transplantation as treatment for patients with DOCK8 deficiency","volume":"7","author":"Aydin","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.11.406","article-title":"HSCT for DOCK8 deficiency - an international study on 74 patients","volume":"22","author":"Aydin","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B162","doi-asserted-by":"publisher","first-page":"e43360","DOI":"10.7759\/cureus.43360","article-title":"Efficacy of dupilumab in treating atopic dermatitis with recurrent eczema herpeticum in a patient with DOCK8-deficiency hyper-IgE syndrome: A case report","volume":"15","author":"Johar","year":"2023","journal-title":"Cureus"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-014-0126-0","article-title":"DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients","volume":"35","author":"Aydin","year":"2015","journal-title":"J Clin Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat4941","article-title":"ZNF341 controls STAT3 expression and thereby immunocompetence","volume":"3","author":"Frey-Jakobs","year":"2018","journal-title":"Sci Immunol"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat4956","article-title":"A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity","volume":"3","author":"Beziat","year":"2018","journal-title":"Sci Immunol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"102326","DOI":"10.1016\/j.coi.2023.102326","article-title":"Inherited human ZNF341 deficiency","volume":"82","author":"Beziat","year":"2023","journal-title":"Curr Opin Immunol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00751-4","article-title":"Efficacy of dupilumab for controlling severe atopic dermatitis in a patient with hyper-IgE syndrome","volume":"40","author":"Levy","year":"2020","journal-title":"J Clin Immunol"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B170","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032406","article-title":"Multi-omics profiling in PGM3 and STAT3 deficiencies: A tale of two patients","volume":"24","author":"Jacob","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.047","article-title":"Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3","volume":"137","author":"Bernth-Jensen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1111\/pai.13398","article-title":"Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features","volume":"32","author":"Garcia-Garcia","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-019-00693-6","article-title":"Compound heterozygous PGM3 mutations in a Thai patient with a specific antibody deficiency requiring monthly IVIG infusions","volume":"40","author":"Ittiwut","year":"2020","journal-title":"J Clin Immunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.10.002","article-title":"Susceptibility to infections, without concomitant hyper-IgE, reported in 1976, is caused by hypomorphic mutation in the phosphoglucomutase 3 (PGM3) gene","volume":"161","author":"Lundin","year":"2015","journal-title":"Clin Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12887-018-1258-9","article-title":"Eleven percent intact PGM3 in a severely immunodeficient patient with a novel splice-site mutation, a case report","volume":"18","author":"Lundin","year":"2018","journal-title":"BMC Pediatr"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3173","article-title":"A novel PGM3 mutation is associated with a severe phenotype of bone marrow failure, severe combined immunodeficiency, skeletal dysplasia, and congenital malformations","volume":"32","author":"Pacheco-Cuellar","year":"2017","journal-title":"J Bone Miner Res"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-021-00985-w","article-title":"Two novel homozygous mutations in phosphoglucomutase 3 leading to severe combined immunodeficiency, skeletal dysplasia, and malformations","volume":"41","author":"Fusaro","year":"2021","journal-title":"J Clin Immunol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13223-022-00749-0","article-title":"Novel PGM3 mutation in two siblings with combined immunodeficiency and childhood bullous pemphigoid: a case report and review of the literature","volume":"18","author":"Fallahi","year":"2022","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191002","article-title":"The nature of human IL-6","volume":"216","author":"Puel","year":"2019","journal-title":"J Exp Med"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0320-5","article-title":"Interleukin-6 signaling regulates hematopoietic stem cell emergence","volume":"51","author":"Tie","year":"2019","journal-title":"Exp Mol Med"},{"key":"B183","doi-asserted-by":"publisher","first-page":"e14244","DOI":"10.1111\/pai.14244","article-title":"Cold abscess and high IgE beyond Job\u2019s syndrome: Four cases of IL-6R deficiency","volume":"35","author":"Barman","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s10875-023-01603-7","article-title":"The human GP130 cytokine receptor and its expression-an atlas and functional taxonomy of genetic variants","volume":"44","author":"Chen","year":"2023","journal-title":"J Clin Immunol"},{"key":"B185","volume-title":"Comel Netherton Syndrome","year":"2008"},{"key":"B186","doi-asserted-by":"publisher","first-page":"e1611","DOI":"10.1002\/mgg3.1611","article-title":"A novel SPINK5 donor splice site variant in a child with\u00a0Netherton syndrome","volume":"9","author":"Mintoff","year":"2021","journal-title":"Mol Genet Genomic Med"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01663.x","article-title":"Elevated stratum corneum hydrolytic activity in Netherton syndrome suggests an inhibitory regulation of desquamation by SPINK5-derived peptides","volume":"118","author":"Komatsu","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1159\/000514699","article-title":"Netherton syndrome: case report and review of the literature","volume":"7","author":"Herz-Ruelas","year":"2021","journal-title":"Skin Appendage Disord"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-016-0243-y","article-title":"Netherton syndrome: A genotype-phenotype review","volume":"21","author":"Sarri","year":"2017","journal-title":"Mol Diagn Ther"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.5070\/D3257044805","article-title":"Two siblings affected by Netherton\/Comel syndrome. Diagnostic pathology and description of a new SPINK5 variant","volume":"25","author":"Schepis","year":"2019","journal-title":"Dermatol Online J"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.2478\/bjmg-2020-0012","article-title":"A new splice-site mutation of SPINK5 gene in the netherton syndrome with different clinical features: A case report","volume":"23","author":"Erden","year":"2020","journal-title":"Balkan J Med Genet"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16883","article-title":"Response to dupilumab in two children with Netherton syndrome: Improvement of pruritus and scaling","volume":"35","author":"Sussmuth","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2021.03.003","article-title":"Successful dupilumab treatment for ichthyotic and atopic features of Netherton syndrome","volume":"102","author":"Murase","year":"2021","journal-title":"J Dermatol Sci"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.4608","article-title":"Treatment of Netherton syndrome with dupilumab","volume":"156","author":"Steuer","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14317","article-title":"Successful treatment with dupilumab of an adult with Netherton syndrome","volume":"45","author":"Andreasen","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.3109\/08923973.2015.1115518","article-title":"A case of netherton syndrome: successful treatment with omalizumab and pulse prednisolone and its effects on cytokines and immunoglobulin levels","volume":"38","author":"Yalcin","year":"2016","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.v183.1","article-title":"Successful treatment of Netherton syndrome with ustekinumab in a 15-year-old girl","volume":"183","author":"Volc","year":"2020","journal-title":"Br J Dermatol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000525987","article-title":"Treatment experiences with intravenous immunoglobulins, ixekizumab, dupilumab, and anakinra in Netherton syndrome: A case series","volume":"239","author":"Ragamin","year":"2023","journal-title":"Dermatology"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2017.07.019","article-title":"Infliximab therapy for Netherton syndrome: A case report","volume":"3","author":"Roda","year":"2017","journal-title":"JAAD Case Rep"},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.07.1513","article-title":"A combination therapy with secukinumab and dupilumab in Netherton syndrome: A prospective pilot study","volume":"91","author":"Liu","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for Netherton syndrome","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.04.025","article-title":"Successful use of secukinumab in Netherton syndrome","volume":"6","author":"Blanchard","year":"2020","journal-title":"JAAD Case Rep"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-018-9767-2","article-title":"Human hyper-IgE syndrome: singular or plural","volume":"29","author":"Zhang","year":"2018","journal-title":"Mamm Genome"},{"key":"B205","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/00005792-198307000-00001","article-title":"The hyperimmunoglobulin E recurrent-infection (Job\u2019s) syndrome. A review of the NIH experience and the literature","volume":"62","author":"Donabedian","year":"1983","journal-title":"Med (Baltimore)"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804093381516","article-title":"The interleukin-4 receptor variant Q576R in hyper-IgE syndrome","volume":"338","author":"Grimbacher","year":"1998","journal-title":"N Engl J Med"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0610289104","article-title":"Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease","volume":"104","author":"Milner","year":"2007","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B208","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12026-011-8205-2","article-title":"Transcriptional regulation by STAT6","volume":"50","author":"Goenka","year":"2011","journal-title":"Immunol Res"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1111\/all.2014.69.issue-7","article-title":"Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern","volume":"69","author":"Boos","year":"2014","journal-title":"Allergy"},{"key":"B210","doi-asserted-by":"publisher","first-page":"564926","DOI":"10.1155\/2014\/564926","article-title":"Clinical case of immune dysregulation, polyendocrinopaty, enteropathy, X-linked (IPEX) syndrome with severe immune deficiency and late onset of endocrinopathy and enteropathy","volume":"2014","author":"Savova","year":"2014","journal-title":"Case Rep Med"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.jaci.2015.11.017","article-title":"Food allergies can persist after myeloablative hematopoietic stem cell transplantation in dedicator of cytokinesis 8-deficient patients","volume":"137","author":"Happel","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.1111\/all.2017.72.issue-12","article-title":"Spontaneous food allergy in Was(-\/-) mice occurs independent of FcepsilonRI-mediated mast cell activation","volume":"72","author":"Lexmond","year":"2017","journal-title":"Allergy"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.045","article-title":"Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation","volume":"132","author":"Siegel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142434","article-title":"Somatic reversion of pathogenic DOCK8 variants alters lymphocyte differentiation and function to effectively cure DOCK8 deficiency","volume":"131","author":"Pillay","year":"2021","journal-title":"J Clin Invest"},{"key":"B215","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1016\/j.jaip.2019.02.041","article-title":"Spectrum of pulmonary aspergillosis in hyper-IgE syndrome with autosomal-dominant STAT3 deficiency","volume":"7","author":"Dureault","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.016","article-title":"Dedicator of cytokinesis 8-deficient CD4(+) T cells are biased to a T(H)2 effector fate at the expense of T(H)1 and T(H)17 cells","volume":"139","author":"Tangye","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.05.003","article-title":"STAT6 joins the gain-of-function club","volume":"152","author":"Chen","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1066375","article-title":"Dysregulation of the immune response in TGF-beta signalopathies","volume":"13","author":"Rodari","year":"2022","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1516068\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:52:07Z","timestamp":1739861527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1516068\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":218,"alternative-id":["10.3389\/fimmu.2025.1516068"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1516068","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"article-number":"1516068"}}